CLOCK and neoplasm: In respect to the known capacity of miR-34a to attenuate tumour growth [66], its influence on the circadian oscillator differs from that usually reported, as clock genes that are inhibited by miR-34 administration (per2 and bmal1) are more often mentioned in the context of tumour suppression than the opposite.